Better cholesterol drugs may follow SLU researcher's breakthrough

October 5, 2010

Thanks to a discovery by a Saint Louis University researcher, scientists have identified an important microRNA that may allow us to better control cholesterol levels in blood.

Led by Angel Baldan, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University and published in a recent issue of , the study found that the miR-33, may be key to controlling HDL, or "good" .

In the U.S., heart attack, stroke, and collectively account for more than 30 percent of all deaths in the last decade. Atherosclerosis, the fatty build-up in arteries that causes these illnesses, is tied to cholesterol levels, a waxy substance found in the blood.

Statins, drugs frequently prescribed by doctors to manage cholesterol levels, work by lowering LDL, or "bad" cholesterol levels; however, their role in HDL cholesterol is still obscure. Importantly, HDL has been found to have a protective benefit against cardiovascular disease.

"Atherosclerosis costs lives and takes an enormous toll on our health," said Baldan. "If the discovery that miR-33 can be used to raise HDL levels leads to better medications, it will have an enormous impact on our ability to treat heart disease."

The study, which was funded by the National Institutes of Health, Saint Louis University Center for Cardiovascular Research and the Doisy Department of Biochemistry and Molecular Biology at Saint Louis University, examined SREBP-2, an important gene in the body, and zeroed in on the microRNA miR-33, which is expressed within SREBP-2.

Increasing the levels of miR-33 in the liver, scientists discovered, resulted in lower HDL cholesterol levels in an animal model; conversely, turning off miR-33, researchers found, had the effect of raising HDL levels.

Paralleling these results, four separate studies reported similar findings, adding to investigators' hope that better medications may be on the horizon for managing atherosclerosis. Scientists hope that future medications may prove to be more effective than statins alone by not only lowering LDL-cholesterol levels, but also increasing HDL levels.

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

junkd
not rated yet Nov 29, 2010
Reliable supplier, rapid delivery, guarantee!
http://star-of-he..._id=5831

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.